Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Falck

Showing results (611-620 of 651) with videos related to

Pageof 66
Sort By:
Cancer Research|July 18, 2018
The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid ProductionLindsay N Sausville, Mahesha H Gangadhariah, Manuel Chiusa, et al.
Journal of Cardiovascular Pharmacology|March 24, 2022
Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic ShockBahar Tunctan, Sefika Pinar Senol, Meryem Temiz-Resitoglu, et al.
The Journal of Biological Chemistry|August 6, 2005
Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4Xixuan H Collins, Shawn D Harmon, Terry L Kaduce, et al.
Frontiers in Pharmacology|March 19, 2019
Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive <i>Ren-2</i> Transgenic RatsJaroslav Hrdlička, Jan Neckář, František Papoušek, et al.
Clinical Science (London, England : 1979)|January 7, 2010
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic ratsVera Certíková Chábová, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, et al.
Journal of Medicinal Chemistry|August 6, 2009
14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibitionJ R Falck, Ravinder Kodela, Rajkumar Manne, et al.
Nitric Oxide : Biology and Chemistry|May 21, 2013
Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shockBahar Tunctan, Belma Korkmaz, Ayse Nihal Sari, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertensionV R Holla, F Adas, J D Imig, et al.
Circulation Research|July 8, 2000
Production of 20-HETE and its role in autoregulation of cerebral blood flowD Gebremedhin, A R Lange, T F Lowry, et al.
Plos One|September 12, 2013
CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophyChristina Westphal, Bastian Spallek, Anne Konkel, et al.
Pageof 66

Showing results (611-620 of 651) with videos related to

Sort By:
Pageof 66
Cancer Research|July 18, 2018
The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid ProductionLindsay N Sausville, Mahesha H Gangadhariah, Manuel Chiusa, et al.
Journal of Cardiovascular Pharmacology|March 24, 2022
Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic ShockBahar Tunctan, Sefika Pinar Senol, Meryem Temiz-Resitoglu, et al.
The Journal of Biological Chemistry|August 6, 2005
Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4Xixuan H Collins, Shawn D Harmon, Terry L Kaduce, et al.
Frontiers in Pharmacology|March 19, 2019
Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive <i>Ren-2</i> Transgenic RatsJaroslav Hrdlička, Jan Neckář, František Papoušek, et al.
Clinical Science (London, England : 1979)|January 7, 2010
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic ratsVera Certíková Chábová, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, et al.
Journal of Medicinal Chemistry|August 6, 2009
14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibitionJ R Falck, Ravinder Kodela, Rajkumar Manne, et al.
Nitric Oxide : Biology and Chemistry|May 21, 2013
Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shockBahar Tunctan, Belma Korkmaz, Ayse Nihal Sari, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2001
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertensionV R Holla, F Adas, J D Imig, et al.
Circulation Research|July 8, 2000
Production of 20-HETE and its role in autoregulation of cerebral blood flowD Gebremedhin, A R Lange, T F Lowry, et al.
Plos One|September 12, 2013
CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophyChristina Westphal, Bastian Spallek, Anne Konkel, et al.
Pageof 66